Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Recurrent Breast Carcinoma”

1,352 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 1,352 results

Not applicableUnknownNCT04145973
What this trial is testing

Evaluation of Prognostic Monitoring for Breast Cancer Patients With Recurrence and Metastasis After Surgery

Who this might be right for
Breast Cancer
Peking Union Medical College Hospital 200
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07005583
What this trial is testing

Clinical Study of QL1706 in Combination With Olaparib for the Treatment of Patients With Previously Treated Homologous Recombination Repair-Deficient Recurrent or Metastatic Triple-Negative Breast Cancer

Who this might be right for
Triple-Negative Breast Cancer (TNBC)
Tianjin Medical University Cancer Institute and Hospital 46
Large-scale testing (Phase 3)Study completedNCT00390455
What this trial is testing

Fulvestrant With or Without Lapatinib in Treating Postmenopausal Women With Stage III or Stage IV Breast Cancer That is Hormone Receptor-Positive

Who this might be right for
Estrogen Receptor PositiveHER2 Positive Breast CarcinomaHER2/Neu Negative+5 more
National Cancer Institute (NCI) 295
Testing effectiveness (Phase 2)Study completedNCT00003540
What this trial is testing

Gemcitabine in Treating Women With Metastatic Breast Cancer Previously Treated With Doxorubicin and Paclitaxel

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 30
Not applicableStudy completedNCT02171078
What this trial is testing

Post-Treatment Surveillance in Breast Cancer: Bringing CER to the Alliance

Who this might be right for
Breast Neoplasms
University of Wisconsin, Madison 34,359
Testing effectiveness (Phase 2)Study completedNCT00755885
What this trial is testing

Abiraterone Acetate in Treating Postmenopausal Women With Advanced or Metastatic Breast Cancer

Who this might be right for
Breast Cancer
Cancer Research UK 77
Testing effectiveness (Phase 2)Study completedNCT00020176
What this trial is testing

Allogeneic Peripheral Stem Cell Transplantation in Treating Patients With Stage IV Breast Cancer

Who this might be right for
Breast Cancer
National Cancer Institute (NCI)
Large-scale testing (Phase 3)Study completedNCT02819518
What this trial is testing

Study of Pembrolizumab (MK-3475) Plus Chemotherapy vs. Placebo Plus Chemotherapy for Previously Untreated Locally Recurrent Inoperable or Metastatic Triple Negative Breast Cancer (MK-3475-355/KEYNOTE-355)

Who this might be right for
Triple Negative Breast Cancer (TNBC)
Merck Sharp & Dohme LLC 882
Not applicableLooking for participantsNCT06704659
What this trial is testing

Study on Recurrent Breast Cancer and Repeated Radiation Therapy

Who this might be right for
Recurrent Breast Carcinoma
Turku University Hospital 60
Not applicableLooking for participantsNCT06382818
What this trial is testing

Personalization of Breast Radiotherapy According to Loco-regional Recurrence Risk and Toxicity Probability

Who this might be right for
Breast Cancer
Institut du Cancer de Montpellier - Val d'Aurelle 854
Not applicableStudy completedNCT01617954
What this trial is testing

PRospective Study Of MammaPrint in Patients With an Intermediate Recurrence Score

Who this might be right for
Hormone Receptor Positive Malignant Neoplasm of Breast
Agendia 820
Testing effectiveness (Phase 2)Looking for participantsNCT07410494
What this trial is testing

Biomarker-Guided Allogeneic Single-Target or Dual-Target CAR-NK Cell Therapy for Advanced Solid Tumors

Who this might be right for
CancerBreast CancerNon-Small Cell Lung Cancer (NSCLC)+10 more
Essen Biotech 85
Not applicableEnded earlyNCT02149173
What this trial is testing

F-18 FES PET/CT in Measuring Hormone Expression in Patients With Primary, Recurrent, or Metastatic Breast Cancer Undergoing Endocrine-Targeted Therapy

Who this might be right for
Estrogen Receptor PositiveRecurrent Breast CarcinomaStage IV Breast Cancer AJCC v6 and v7
University of Washington 29
Not applicableLooking for participantsNCT06185569
What this trial is testing

FREDO-ODX Study: FREnch Data on Outcomes in HR+/HER2- Early Breast Cancer Patients With oncotypeDX Recurrence Score-guided Therapy

Who this might be right for
Breast Cancer
Centre Hospitalier Universitaire de Besancon 4,500
Early research (Phase 1)Study completedNCT00068757
What this trial is testing

Lonafarnib, Trastuzumab, and Paclitaxel in Treating Patients With HER2/Neu-Overexpressing Stage IIIB, Stage IIIC, or Stage IV Breast Cancer

Who this might be right for
Breast Cancer
European Organisation for Research and Treatment of Cancer - EORTC 23
Not applicableUnknownNCT06088719
What this trial is testing

Safety of Omitting Axillary Surgery in Breast Cancer Patients With Isolated Chest Wall Recurrence

Who this might be right for
Breast CancerRecurrent Disease
KK Women's and Children's Hospital 300
Early research (Phase 1)Study completedNCT00569283
What this trial is testing

Donor Natural Killer Cell Infusion in Preventing Relapse or Graft Failure in Patients Who Have Undergone Donor Bone Marrow Transplant

Who this might be right for
Cancer
Asan Medical Center 18
Not applicableStudy completedNCT00897702
What this trial is testing

Molecular Mechanisms of Clinical Resistance to Targeted Therapy Among Patients With Breast Cancer

Who this might be right for
Breast Cancer
Memorial Sloan Kettering Cancer Center 269
Post-approval studies (Phase 4)UnknownNCT00912639
What this trial is testing

A Clinical Trial of Paclitaxel Loaded Polymeric Micelle in Patients With Taxane-Pretreated Recurrent Breast Cancer

Who this might be right for
Recurrent Breast Cancer
Korean Breast Cancer Study Group 90
Testing effectiveness (Phase 2)Study completedNCT00368875
What this trial is testing

Phase I-II Study of Vorinostat, Paclitaxel, and Bevacizumab in Metastatic Breast Cancer

Who this might be right for
Male Breast CancerStage IIIB Breast CancerStage IIIC Breast Cancer+1 more
National Cancer Institute (NCI) 54
Load More Results